General Information
BounceWatch is an independent company data service, not affiliated with Adastra Pharmaceuticals. To contact Adastra Pharmaceuticals, visit adastrarx.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
United States Market
Biotechnology
About Adastra Pharmaceuticals
Taxonomy: oncology, biopharmaceutical, clinical-stage, cancer care, pharmaceuticals, multi-kinase inhibitor, San Diego, drug development, precision medicine, clinical trials, innovation
Funding Rounds & Investors (10)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | $3.26M | - |
|
15 Nov 2016 |
| Venture Round | $13.06M | - |
|
28 Aug 2015 |
| Series C | $4.80M | 1 | 01 Aug 2015 | |
| Debt Financing | $1.20M | - |
|
17 Jul 2015 |
| Convertible Note | $1.32M | 1 | 01 Jul 2015 | |
| Series B | $3.00M | 1 | 14 Apr 2014 | |
| Series B | $9.36M | 1 | 29 Aug 2013 | |
| Debt Financing | $4.00M | - |
|
08 Aug 2012 |
| Venture Round | $5.00M | 5 | 15 Apr 2010 | |
| Series A | $40.00M | 5 | 15 Mar 2007 |
Adastra Pharmaceuticals Alternatives & Competitors
We are on a mission to deliver transformative therapies that treat rare forms of cancer.
Committed to developing therapies to extend and enhance the quality of life.
Dedicated to transforming the lives of patients with rare hematologic diseases and cancers.
FAQ About Adastra Pharmaceuticals
Source: BounceWatch company record for Adastra Pharmaceuticals, https://bouncewatch.com/company/adastra-pharmaceuticals, updated 28 October 2024. When citing, please name BounceWatch and link this page.